Elevance Health Return on Tangible Equity 2010-2025 | ELV
Current and historical return on tangible equity values for Elevance Health (ELV) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
| Elevance Health Return On Tangible Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Tangible Equity | Return on Tangible Equity |
| 2025-03-31 | $5.92B | $2.26B | 140.96% |
| 2024-12-31 | $5.98B | $1.06B | 128.72% |
| 2024-09-30 | $6.42B | $7.59B | 120.28% |
| 2024-06-30 | $6.69B | $5.89B | 162.08% |
| 2024-03-31 | $6.24B | $4.05B | 192.72% |
| 2023-12-31 | $5.99B | $3.82B | 235.27% |
| 2023-09-30 | $6.00B | $2.76B | 299.95% |
| 2023-06-30 | $6.31B | $2.34B | 396.54% |
| 2023-03-31 | $6.09B | $1.27B | 511.24% |
| 2022-12-31 | $5.89B | $1.63B | 502.90% |
| 2022-09-30 | $6.22B | $1.13B | 573.14% |
| 2022-06-30 | $6.13B | $0.74B | 599.12% |
| 2022-03-31 | $6.28B | $1.19B | 726.45% |
| 2021-12-31 | $6.16B | $1.29B | 480.62% |
| 2021-09-30 | $5.52B | $0.88B | 371.39% |
| 2021-06-30 | $4.23B | $0.11B | 216.84% |
| 2021-03-31 | $4.71B | $2.86B | 172.44% |
| 2020-12-31 | $4.57B | $2.10B | 215.25% |
| 2020-09-30 | $4.96B | $2.74B | 221.53% |
| 2020-06-30 | $5.92B | $3.24B | 285.59% |
| 2020-03-31 | $4.78B | $0.42B | 294.00% |
| 2019-12-31 | $4.81B | $2.55B | 288.88% |
| 2019-09-30 | $4.30B | $2.08B | 548.79% |
| 2019-06-30 | $4.07B | $1.45B | 2804.82% |
| 2019-03-31 | $3.99B | $0.57B | -893.39% |
| 2018-12-31 | $3.75B | $-0.97B | -325.52% |
| 2018-09-30 | $4.56B | $-0.48B | -385.04% |
| 2018-06-30 | $4.34B | $-0.91B | -464.72% |
| 2018-03-31 | $4.15B | $-2.25B | -902.56% |
| 2017-12-31 | $3.84B | $-1.10B | 1507.06% |
| 2017-09-30 | $2.98B | $0.52B | 705.56% |
| 2017-06-30 | $2.85B | $0.99B | 3355.29% |
| 2017-03-31 | $2.78B | $0.61B | -545.78% |
| 2016-12-31 | $2.47B | $-0.43B | -207.34% |
| 2016-09-30 | $2.28B | $-0.83B | -130.14% |
| 2016-06-30 | $2.32B | $-1.39B | -106.46% |
| 2016-03-31 | $2.40B | $-2.12B | -95.12% |
| 2015-12-31 | $2.56B | $-2.68B | -107.89% |
| 2015-09-30 | $2.89B | $-2.53B | -151.81% |
| 2015-06-30 | $2.86B | $-2.76B | -194.93% |
| 2015-03-31 | $2.73B | $-1.53B | -280.77% |
| 2014-12-31 | $2.57B | $-0.79B | -309.27% |
| 2014-09-30 | $2.21B | $-0.80B | -282.74% |
| 2014-06-30 | $2.24B | $-0.78B | -227.01% |
| 2014-03-31 | $2.31B | $-0.96B | -180.54% |
| 2013-12-31 | $2.49B | $-0.59B | -156.17% |
| 2013-09-30 | $2.81B | $-1.61B | -148.91% |
| 2013-06-30 | $2.84B | $-1.94B | -237.31% |
| 2013-03-31 | $2.68B | $-2.23B | -577.20% |
| 2012-12-31 | $2.66B | $-1.75B | 492.08% |
| 2012-09-30 | $2.53B | $1.14B | 186.84% |
| 2012-06-30 | $2.52B | $0.98B | 163.84% |
| 2012-03-31 | $2.58B | $1.79B | 125.69% |
| 2011-12-31 | $2.65B | $1.50B | 115.30% |
| 2011-09-30 | $2.86B | $1.88B | 111.80% |
| 2011-06-30 | $2.92B | $3.03B | 102.36% |
| 2011-03-31 | $2.94B | $2.77B | 109.05% |
| 2010-12-31 | $2.89B | $2.55B | 104.27% |
| 2010-09-30 | $5.08B | $3.04B | 171.29% |
| 2010-06-30 | $5.07B | $2.41B | 202.01% |
| 2010-03-31 | $5.04B | $3.08B | 253.29% |
| 2009-12-31 | $4.75B | $3.34B | 454.82% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $85.975B | $177.011B |
| Elevance Health Inc. operates as a health benefits company. It supports consumers, families and communities across the entire care journey connecting to the care, support and resources to lead healthier lives. Elevance Health Inc., formerly known as Anthem Inc., is based in Indianapolis, Indiana. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $136.314B | 25.57 |
| CVS Health (CVS) | United States | $79.418B | 9.87 |
| Cencora (COR) | United States | $56.343B | 19.60 |
| DiDi Global (DIDIY) | China | $22.968B | 34.86 |
| Natera (NTRA) | United States | $21.581B | 0.00 |
| BioMerieux (BMXMF) | France | $15.705B | 0.00 |
| Solventum (SOLV) | United States | $12.562B | 13.30 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $12.357B | 0.00 |
| CochLear (CHEOY) | Australia | $11.324B | 0.00 |
| Revvity (RVTY) | United States | $10.833B | 18.64 |
| ICON (ICLR) | Ireland | $10.585B | 9.84 |
| Viatris (VTRS) | United States | $10.364B | 3.56 |
| Doximity (DOCS) | United States | $9.697B | 45.17 |
| Avantor (AVTR) | United States | $8.886B | 12.91 |
| HealthEquity (HQY) | United States | $8.734B | 42.97 |
| Medpace Holdings (MEDP) | United States | $8.538B | 22.68 |
| Sonic Healthcare (SKHHY) | Australia | $8.205B | 0.00 |
| Charles River Laboratories (CRL) | United States | $6.763B | 13.25 |
| Amplifon S.p.A (AMFPF) | Italy | $4.966B | 27.18 |
| Bausch + Lomb (BLCO) | Canada | $4.142B | 24.42 |
| BrightSpring Health Services (BTSG) | United States | $4.077B | 37.74 |
| Sotera Health (SHC) | United States | $3.514B | 19.97 |
| Alignment Healthcare (ALHC) | United States | $2.948B | 0.00 |
| Surgery Partners (SGRY) | United States | $2.922B | 38.00 |
| Concentras Parent (CON) | United States | $2.767B | 15.99 |
| Organon (OGN) | United States | $2.480B | 2.64 |
| Ardent Health Partners (ARDT) | United States | $2.103B | 8.96 |
| GeneDx Holdings (WGS) | United States | $1.997B | 76.90 |
| Premier (PINC) | United States | $1.891B | 14.36 |
| Progyny (PGNY) | United States | $1.829B | 40.26 |
| PACS (PACS) | United States | $1.513B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.361B | 27.21 |
| Teladoc Health (TDOC) | United States | $1.225B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.222B | 9.30 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.011B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.003B | 0.00 | |
| Agilon Health (AGL) | United States | $0.923B | 0.00 |
| CareDx (CDNA) | United States | $0.922B | 14.40 |
| Nutex Health (NUTX) | United States | $0.921B | 13.91 |
| AMN Healthcare Services Inc (AMN) | United States | $0.807B | 7.56 |
| QDM (QDMI) | Hong Kong, SAR China | $0.743B | 0.00 |
| Embecta (EMBC) | United States | $0.611B | 4.12 |
| InnovAge Holding (INNV) | United States | $0.547B | 0.00 |
| Enhabit (EHAB) | United States | $0.523B | 43.04 |
| LifeMD (LFMD) | United States | $0.522B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.482B | 10.85 |
| SBC Medicals (SBC) | United States | $0.482B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.461B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.387B | 0.00 |
| Oncology Institute (TOI) | United States | $0.286B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.224B | 0.00 |
| Beauty Health (SKIN) | United States | $0.203B | 0.00 |
| KindlyMD (KDLY) | United States | $0.150B | 0.00 |
| DocGo (DCGO) | United States | $0.139B | 22.67 |
| KindlyMD (NAKA) | United States | $0.135B | 0.00 |
| OncoCyte (OCX) | United States | $0.093B | 0.00 |
| So-Young (SY) | China | $0.093B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.069B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.062B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.057B | 0.00 |
| Biodesix (BDSX) | United States | $0.048B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.039B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.032B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.019B | 0.00 |
| ModivCare (MODV) | United States | $0.019B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.012B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.010B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.010B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.007B | 0.00 | |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| INVO Fertility (IVF) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |